United States · FDA National Drug Code directory
Doxepin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55801-531_897d1512-3e1a-469e-bcb9-131e514ed562
- Product NDC
- 55801-531
- Form
- CAPSULE
- Composition / generic term
- Doxepn Hydrochloride
- Labeler
- Appco Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210601
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (55801-531-01) · 55801-531-01
- 500 CAPSULE in 1 BOTTLE (55801-531-02) · 55801-531-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →